Profile data is unavailable for this security.
About the company
Enzolytics, Inc. is a drug development company. The Company is engaged in the commercialization of its proteins and monoclonal antibodies for the treatment of debilitating infectious diseases. Its patented and clinically tested compound, ITV-1 (Immune Therapeutic Vaccine-1), is a suspension of Inactivated Pepsin Fraction (IPF) for the treatment of human immunodeficiency virus/ acquired immunodeficiency syndrome (HIV/AIDS). It has a technology for producing fully human monoclonal antibodies (mAbs) against infectious diseases which is being employed to produce monoclonal antibody therapeutics for treating the Coronavirus (SARS-CoV-2), HIV-1 and the Feline Leukemia virus. The Company also plans to produce mAbs targeting many other viruses, including HIV-2, Influenza A and B, H1N1 influenza, Respiratory syncytial virus (RSV), Small-Pox, Ebola Virus, Tetanus, Diphtheria, HTLV-1/2, Rabies, Herpes zoster, Varicella zoster, Anthrax, Mason-Pfizer monkey virus (MPMV) and Visna virus (VISNA).
- Revenue in USD (TTM)0.00
- Net income in USD-119.19k
- Incorporated2020
- Employees2.00
- LocationEnzolytics Inc120 W Pomona AveMONROVIA 91016United StatesUSA
- Phone+1 (626) 538-4779
- Fax+1 (845) 818-3588
- Websitehttps://enzolytics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CERo Therapeutics Holdings Inc | 0.00 | -2.54m | 5.52m | 8.00 | -- | -- | -- | -- | -0.3796 | -0.3796 | 0.00 | -0.9226 | 0.00 | -- | -- | 0.00 | -9.96 | -- | -33.80 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -279.82 | -- | -- | -- |
Yubo International Biotech Ltd | 454.29k | -1.42m | 5.52m | 18.00 | -- | -- | -- | 12.16 | -0.0118 | -0.0118 | 0.0038 | -0.0211 | 0.2462 | 0.5986 | 3.49 | 25,238.33 | -82.33 | -- | -- | -- | 80.30 | -- | -334.36 | -- | 0.1707 | -4,795.69 | -- | -- | 479.86 | -- | 0.8224 | -- | -- | -- |
Clearmind Medicine Inc | 0.00 | -8.44m | 5.68m | -- | -- | 1.60 | -- | -- | -12.73 | -12.73 | 0.00 | 0.8728 | 0.00 | -- | -- | -- | -133.31 | -218.20 | -266.82 | -488.96 | -- | -- | -- | -- | -- | -2.60 | 0.0172 | -- | -- | -- | -25.03 | -- | -- | -- |
Eterna Therapeutics Inc | 162.00k | -23.94m | 5.68m | 8.00 | -- | -- | -- | 35.07 | -4.42 | -4.42 | 0.0299 | -1.58 | 0.0035 | -- | 0.2673 | 20,250.00 | -51.20 | -169.05 | -62.39 | -223.00 | -111.11 | -- | -14,765.43 | -682.61 | -- | -10.12 | 10.22 | -- | -- | -68.89 | 11.84 | -- | -58.86 | -- |
Galmed Pharmaceuticals Ltd | 0.00 | -5.88m | 5.89m | 3.00 | -- | 0.1758 | -- | -- | -24.68 | -24.68 | 0.00 | 22.25 | 0.00 | -- | -- | 0.00 | -44.20 | -45.06 | -52.67 | -50.79 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 61.31 | -- | -- | -- |
NLS Pharmaceutics AG | 0.00 | -12.17m | 5.97m | 3.00 | -- | -- | -- | -- | -12.75 | -12.75 | 0.00 | -10.90 | 0.00 | -- | -- | 0.00 | -218.86 | -272.62 | -- | -- | -- | -- | -- | -- | -- | -81.34 | -- | -- | -- | -- | 26.21 | -- | -- | -- |
Adial Pharmaceuticals Inc | 0.00 | -12.19m | 6.08m | 4.00 | -- | 0.9536 | -- | -- | -5.26 | -5.30 | 0.00 | 0.9961 | 0.00 | -- | -- | 0.00 | -279.27 | -182.35 | -320.96 | -235.45 | -- | -- | -- | -- | -- | -14.25 | 0.00 | -- | -- | -- | 35.14 | -- | -- | -- |
Enzolytics Inc | 0.00 | -119.19k | 6.22m | 2.00 | -- | -- | -- | -- | -0.106 | -0.106 | 0.00 | -1.04 | 0.00 | -- | -- | -- | -369.52 | -- | -- | -- | -- | -- | -- | -- | -- | -4.30 | -- | -- | -100.00 | -- | -9.35 | -- | -- | -- |
Xenetic Biosciences Inc | 2.52m | -4.70m | 6.24m | 4.00 | -- | 0.8374 | -- | 2.48 | -3.05 | -3.05 | 1.64 | 4.83 | 0.2314 | -- | -- | 630,087.50 | -43.12 | -48.91 | -48.61 | -52.82 | -- | -- | -186.33 | -682.42 | -- | -- | 0.00 | -- | 48.80 | -- | 36.90 | -- | -- | -- |
CeCors Inc | -100.00bn | -100.00bn | 6.24m | 6.00 | -- | -- | -- | -- | -- | -- | -- | -0.0163 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 22.70 | -- | -- | -- |
Cardio Diagnostics Holdings Inc | 39.14k | -8.77m | 6.41m | 7.00 | -- | 1.59 | -- | 163.87 | -0.4899 | -0.4899 | 0.0021 | 0.1319 | 0.0073 | -- | 9.13 | 5,591.43 | -163.16 | -- | -268.73 | -- | -- | -- | -22,414.13 | -- | -- | -9.32 | 0.0295 | -- | 1,696.84 | -- | -79.72 | -- | -- | -- |
Intelligent Bio Solutions Inc | 3.11m | -10.16m | 6.50m | 13.00 | -- | 0.6348 | -- | 2.09 | -39.72 | -39.72 | 2.31 | 2.41 | 0.2579 | 1.92 | 8.60 | 239,366.90 | -84.45 | -71.59 | -156.10 | -144.36 | 45.81 | -- | -327.50 | -565.48 | 1.42 | -- | 0.0592 | -- | 147.58 | 596.39 | 4.47 | -- | -- | -- |
TFF Pharmaceuticals Inc | 1.20m | -19.39m | 6.52m | 19.00 | -- | 1.04 | -- | 5.42 | -7.95 | -7.95 | 0.4659 | 1.81 | 0.1043 | -- | 3.51 | 63,293.68 | -168.10 | -79.57 | -212.66 | -83.41 | -- | -- | -1,612.04 | -8,687.66 | -- | -- | 0.00 | -- | 48.01 | -- | 33.13 | -- | -- | -- |
ABVC Biopharma Inc | 136.40k | -11.37m | 6.67m | 16.00 | -- | 0.7808 | -- | 48.93 | -1.78 | -1.78 | 0.0172 | 0.6882 | 0.0114 | -- | 0.4213 | 8,525.00 | -99.79 | -103.38 | -197.79 | -231.54 | -24.11 | 76.25 | -8,762.13 | -2,019.89 | -- | -2.50 | 0.1873 | -- | -84.28 | 85.39 | 35.97 | -- | -- | -- |
Cannabis Bioscience Internatnl Hlgs Inc | 56.94m | 6.94m | 6.78m | 389.00 | 0.0012 | 0.0001 | 0.735 | 0.1191 | 0.5328 | 0.5328 | 4.29 | 4.92 | 0.5917 | 62.81 | 1.45 | 146,384.30 | 7.83 | -- | 11.73 | -- | 31.96 | -- | 13.24 | -- | 0.6856 | 50.75 | 0.0631 | -- | 12.79 | -- | 177.84 | -- | -- | -- |
Viaderma Inc | 17.80m | 2.31m | 6.79m | 75.00 | 0.0003 | 0.00002 | 1.25 | 0.3812 | 16.84 | 16.84 | 129.62 | 255.59 | 0.4126 | 24.69 | 1.21 | 237,331.30 | 5.36 | -- | 6.53 | -- | 28.90 | -- | 12.99 | -- | 2.07 | 5.66 | 0.1718 | -- | -29.15 | -- | -40.70 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Hilltop Partners LLCas of 30 Jun 2024 | 1.95m | 0.05% |
Vermillion & White Wealth Management Group LLCas of 31 Mar 2024 | 29.86k | 0.00% |
HighPoint Advisor Group LLCas of 30 Jun 2024 | 0.00 | 0.00% |